AR012250A1 - Derivados de 2-(iminometil)amino-fenilo, procedimientos para su preparacion, intermediarios utilizados en dichos procedimientos, medicamento y composicion farmaceutica que contienen a dichos derivados y uso de estos derivados para manufacturar un medicamento - Google Patents

Derivados de 2-(iminometil)amino-fenilo, procedimientos para su preparacion, intermediarios utilizados en dichos procedimientos, medicamento y composicion farmaceutica que contienen a dichos derivados y uso de estos derivados para manufacturar un medicamento

Info

Publication number
AR012250A1
AR012250A1 ARP980102907A ARP980102907A AR012250A1 AR 012250 A1 AR012250 A1 AR 012250A1 AR P980102907 A ARP980102907 A AR P980102907A AR P980102907 A ARP980102907 A AR P980102907A AR 012250 A1 AR012250 A1 AR 012250A1
Authority
AR
Argentina
Prior art keywords
thiazoline
derivatives
radical
branched
linear
Prior art date
Application number
ARP980102907A
Other languages
English (en)
Original Assignee
Ipsen Pharma Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ipsen Pharma Sas filed Critical Ipsen Pharma Sas
Publication of AR012250A1 publication Critical patent/AR012250A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D521/00Heterocyclic compounds containing unspecified hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Derivados de 2-(iminometil)amino-fenilo de la formula general (I): en la cual A es un átomo de hidrogeno o preferiblmente un aromático que tiene lasestructuras de formula (II), en donde R1 y R2 representan, independientemente, hidrogeno, halogeno ,CH, un radical alquilo C1-C6 lineal o ramificado, unradical alcoxi C1-C6 lineal o ramificado, R3 representa hidrogeno, un radical alquilo C1-C6 lineal o ramificado o un radical -COR4, representando R4 unradical alqulo C1-C6 de formula (III), o Brepresenta n radical alqulo C1-C6 lineal o ramificado, fenilo, piridinilo o un heterociclo con 5 miembros conteniendo 1 a 4 heteroátomos elegidos de O, S, N y más particularmente: tiofeno, furano, pirrol o tiazol, cuyos átomos de carbono está nopcionalmentesubstituídos por uno o más grupos elegidos de un radical alquilo C1-C6 lineal o ramificado; un radical alcoxi C1-C6 o halogeno; X representa -CO-N(R3)-X-, -NH-CO-X, -CH=, -CO- o un enlace representando X el resto -CH2)n-, siendo n unentero de 0 a 6, Y representa -Y-, -CO-NH-Y-, -Y-NH-CO, -CO-Y-, -N(R3)-Y,-Y-N(R3)-, -Y-CH2-N(R3)-CO-, -O-Y-,Y-O-, -Y-S-, -Y-O-Y, -Y-N(R3)-Y- o un enlace, Yrepresenta -(CH2)n siendo n un entero de 0 a 6; Het representa unheterociclo que contiene de1 a 5 heteroátomos elegidos de O, N, S, los cuales pueden estar sustituidos por uno o más sustituyentes X-OR3, X-NR3, X-S-R3,tal como por ejemplo: exetano, pirrol, pirrolidina, furano, tetrahidrofurano, tiofeno, tetrahidrotiofeno, sulfolano, imidazol, imidazolina, dihidroimidazol-2-ona, dihidroimidazol-2-tiona, oxazol, isoxazol, oxazolina, isoxazolina, oxaxolidina, oxazoolidinona, tiazol, tiazolina, tiazolidina, tiazolidinona,hidantoina, 1,2,4-tiazol, 1,3,4-oxadiazol, 1,1-dioxido-1,2,5-tiadiazolidina, 1,2,4-triazol-3-ona, tetrazol, tetrahidropirina, con la excepcion de los ..2
ARP980102907A 1997-06-20 1998-06-18 Derivados de 2-(iminometil)amino-fenilo, procedimientos para su preparacion, intermediarios utilizados en dichos procedimientos, medicamento y composicion farmaceutica que contienen a dichos derivados y uso de estos derivados para manufacturar un medicamento AR012250A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9707701A FR2764889B1 (fr) 1997-06-20 1997-06-20 Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
AR012250A1 true AR012250A1 (es) 2000-09-27

Family

ID=9508226

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980102907A AR012250A1 (es) 1997-06-20 1998-06-18 Derivados de 2-(iminometil)amino-fenilo, procedimientos para su preparacion, intermediarios utilizados en dichos procedimientos, medicamento y composicion farmaceutica que contienen a dichos derivados y uso de estos derivados para manufacturar un medicamento

Country Status (29)

Country Link
EP (1) EP0991654B1 (es)
JP (1) JP2002507965A (es)
KR (2) KR100545946B1 (es)
CN (1) CN1195762C (es)
AR (1) AR012250A1 (es)
AT (1) ATE297935T1 (es)
AU (1) AU737964B2 (es)
BR (1) BR9810197B1 (es)
CA (1) CA2294809C (es)
CZ (1) CZ299237B6 (es)
DE (1) DE69830584T2 (es)
DK (1) DK0991654T3 (es)
ES (1) ES2244068T3 (es)
FR (1) FR2764889B1 (es)
HK (1) HK1030218A1 (es)
HU (1) HUP0002425A3 (es)
IL (1) IL133223A (es)
MY (1) MY123193A (es)
NO (1) NO315321B1 (es)
NZ (1) NZ501656A (es)
PL (1) PL191987B1 (es)
PT (1) PT991654E (es)
RU (1) RU2202543C2 (es)
SK (1) SK286911B6 (es)
TR (1) TR199903175T2 (es)
TW (1) TW422842B (es)
UA (1) UA70921C2 (es)
WO (1) WO1998058934A1 (es)
ZA (1) ZA985392B (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9801990D0 (sv) 1998-06-04 1998-06-04 Astra Ab New 3-aryl propionic acid derivatives and analogs
AR019190A1 (es) * 1998-07-08 2001-12-26 Sod Conseils Rech Applic Derivados de 2-aminopiridinas, productos intermedios para su preparacion, medicamentos y composiciones farmaceuticas que los contienen y su uso para preparar medicamentos
WO2000008018A1 (fr) * 1998-08-07 2000-02-17 Takeda Chemical Industries, Ltd. Derives de benzothiepine, leur procede de preparation et leurs utilisations
FR2783519B1 (fr) * 1998-09-23 2003-01-24 Sod Conseils Rech Applic Nouveaux derives d'amidines, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
FR2798127A1 (fr) * 1999-09-03 2001-03-09 Expansia Sa Nouveau procede de preparation d'amidines derivees de l'acide 6-hydroxy-2,5,7,8-tetramethylchrommane-2-carboxy- lique
FR2799461B1 (fr) * 1999-10-11 2002-01-04 Sod Conseils Rech Applic Derives d'heterocycles a 5 chainons, leur preparation et leur application a titre de medicaments
RU2380362C2 (ru) * 1999-10-11 2010-01-27 Сосьете Де Консей Де Решерш З Производные пятичленных гетероциклов, способ их получения и их применение в качестве лекарственных средств
TWI292316B (en) * 1999-10-11 2008-01-11 Sod Conseils Rech Applic Pharmaceutical composition of thiazole derivatives intended to inhibit mao and/or lipidic peroxidation and/or to act as modulators of sodium channels and the use thereof
FR2812546B1 (fr) * 2000-08-01 2008-11-21 Sod Conseils Rech Applic Derives d'heterocycles a 5 chainons, leur preparation et leur application a titre de medicaments
FR2801053B1 (fr) * 1999-11-16 2004-06-25 Sod Conseils Rech Applic Nouveaux derives d'amidines, leur preparation et leur application a titre de medicaments
SE9904677D0 (sv) * 1999-12-20 1999-12-20 Astra Ab Novel compounds
SE9904676D0 (sv) * 1999-12-20 1999-12-20 Astra Ab Novel compounds
GB0019006D0 (en) * 2000-08-04 2000-09-20 Astrazeneca Ab Novel compounds
WO2002020511A1 (en) * 2000-09-05 2002-03-14 Astrazeneca Ab Amidine derivatives which are inhibitors of nitric oxide synthase
TWI248438B (en) * 2001-04-10 2006-02-01 Sod Conseils Rech Applic Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
AU2002314944B2 (en) 2001-06-08 2008-03-06 Cytokine Pharmasciences, Inc. Isoxazoline compounds having MIF antagonist activity
HU228783B1 (en) * 2001-07-26 2013-05-28 Greenearth Cleaning Dry cleaning apparatus and method capable of utilizing a siloxane solvent
FR2842808B1 (fr) * 2002-07-25 2004-09-10 Sod Conseils Rech Applic Nouveaux derives d'arylimidazoles, leur preparation et leurs applications therapeutiques
DE10233817A1 (de) * 2002-07-25 2004-02-12 Aventis Pharma Deutschland Gmbh Substituierte Diarylheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US7141561B2 (en) 2002-07-25 2006-11-28 Sanofi-Aventis Deutschland Gmbh Substituted diaryl heterocycles, process for their preparation and their use as medicaments
CN101098697B (zh) * 2004-03-26 2010-11-10 塞托凯恩药物科学公司 与抑制巨噬细胞游走抑制因子有关的化合物、组合物、其制备方法和使用方法
WO2006022442A1 (ja) * 2004-08-24 2006-03-02 Santen Pharmaceutical Co., Ltd. ジヒドロオロテートデヒドロゲナーゼ阻害活性を有する新規複素環アミド誘導体
BRPI0608402B8 (pt) 2005-03-11 2021-05-25 Armaron Bio Pty Ltd compostos de flavonóide e composições compreendendo os mesmos
AU2010289281A1 (en) 2009-09-04 2012-04-12 Vanderbilt University mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
WO2011058766A1 (en) * 2009-11-16 2011-05-19 Raqualia Pharma Inc. Aryl carboxamide derivatives as ttx-s blockers
JP6292721B2 (ja) * 2012-07-12 2018-03-14 コンドリオン アイピー ビー.ブイ.Khondrion Ip B.V. ミトコンドリア病を治療するためのクロマニル誘導体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9127376D0 (en) * 1991-12-24 1992-02-19 Wellcome Found Amidino derivatives
IL110643A (en) * 1993-08-12 1998-07-15 Astra Ab History of amidine, their preparation and the pharmaceutical preparations containing them
ATE182889T1 (de) * 1994-05-07 1999-08-15 Astra Ab Bicyclische amidinderivate als no-synthetase inhibitoren

Also Published As

Publication number Publication date
WO1998058934A1 (fr) 1998-12-30
FR2764889B1 (fr) 2000-09-01
KR100618478B1 (ko) 2006-09-01
UA70921C2 (uk) 2004-11-15
BR9810197A (pt) 2000-08-08
IL133223A (en) 2004-09-27
AU737964B2 (en) 2001-09-06
JP2002507965A (ja) 2002-03-12
NZ501656A (en) 2001-12-21
FR2764889A1 (fr) 1998-12-24
KR100545946B1 (ko) 2006-01-26
DE69830584D1 (de) 2005-07-21
MY123193A (en) 2006-05-31
HUP0002425A3 (en) 2001-12-28
BR9810197B1 (pt) 2010-02-09
HUP0002425A1 (hu) 2001-11-28
CZ459799A3 (cs) 2000-07-12
CA2294809C (fr) 2010-02-02
EP0991654A1 (fr) 2000-04-12
TR199903175T2 (xx) 2000-04-21
ES2244068T3 (es) 2005-12-01
NO996208L (no) 2000-02-15
CN1195762C (zh) 2005-04-06
SK286911B6 (sk) 2009-07-06
NO315321B1 (no) 2003-08-18
SK179699A3 (en) 2000-05-16
PL191987B1 (pl) 2006-07-31
KR20010013983A (ko) 2001-02-26
CN1264385A (zh) 2000-08-23
RU2202543C2 (ru) 2003-04-20
IL133223A0 (en) 2001-03-19
CZ299237B6 (cs) 2008-05-28
TW422842B (en) 2001-02-21
PL337499A1 (en) 2000-08-28
DE69830584T2 (de) 2006-03-16
KR20050098970A (ko) 2005-10-12
EP0991654B1 (fr) 2005-06-15
ATE297935T1 (de) 2005-07-15
CA2294809A1 (fr) 1998-12-30
PT991654E (pt) 2005-10-31
HK1030218A1 (en) 2001-04-27
DK0991654T3 (da) 2005-10-17
NO996208D0 (no) 1999-12-15
ZA985392B (en) 1999-01-20
AU8218998A (en) 1999-01-04

Similar Documents

Publication Publication Date Title
AR012250A1 (es) Derivados de 2-(iminometil)amino-fenilo, procedimientos para su preparacion, intermediarios utilizados en dichos procedimientos, medicamento y composicion farmaceutica que contienen a dichos derivados y uso de estos derivados para manufacturar un medicamento
PT684945E (pt) Inibidores de acat a base de alquilamida substituida com pirazol ou isoxazol
PE20030200A1 (es) Bencimidazol como inhibidores de las map quinasas
BRPI0213243B8 (pt) composto heterocíclico aromático contendo um anel oxazol, tiazol ou imidazol, ou um sal farmaceuticamente aceitável do mesmo, e, composição farmacêutica
CY1110263T1 (el) Νεες ενωσεις ισοξαζολης και θειαζολης και η χρηση τους ως φαρμακα
KR890005095A (ko) 신규 화합물들
PE20020100A1 (es) DERIVADOS DE 2-SULFONIL AMINO-1,3-TIAZOL COMO INHIBIDORES DE 11-ß-HIDROXI ESTEROIDE DESHIDROGENASA TIPO 1 (11ßHSD1)
HRP20010468B1 (en) Azabicycloalkanes as ccr5 modulators
PE20050018A1 (es) Compuesto pentaciclico heteroaromatico como inhibidor de la proteina tirosina fosfatasa 1b (ptb1b)
DK444581A (da) Beta-lactam-forbindelser og farmaceutisk taalelige salte deraf fremgangsmaade til deres fremstilling og deres anvendelse
AR012102A1 (es) Derivados de 2-(iminometil)amino-fenilo, su preparacion, uso de los mismos para la fabricacion de medicamentos y composiciones farmaceuticas que los contienen.
NZ318515A (en) Cyclodepsipeptide PF1022 derivatives and compositions thereof
CO4940477A1 (es) Inhibidores de proteasa
NZ215175A (en) Barbituric acid derivatives and anthelmintic compositions
IE880331L (en) Substituted 2,6-substituted pyridine compounds
RU2008104422A (ru) Активатор рецептора дельта, активируемого пролифератором
KR910000684A (ko) 소염제 페나메이트 1,3,4-티아디아졸 및 1,3,4-옥사디아졸
NO171166C (no) Analogifremgangsmaate for fremstilling av beta-d-fenyltioxylosider
RU2007135745A (ru) АКТИВАТОР δ- РЕЦЕПТОРА, АКТИВИРУЕМОГО ПРОЛИФЕРАТОРОМ ПЕРОКСИСОМЫ
PE20020600A1 (es) Heteroaromatos como inhibidores de la 2,3-oxidoescualeno-lanosterol ciclasa
KR890002134A (ko) 1,2-벤즈 이속 사졸 및 1,2-벤즈 이소 티아졸 유도체
EA200001230A1 (ru) ПИРИМИДИНАМИНОМЕТИЛПИРИДИНОВЫЕ ПРОИЗВОДНЫЕ, ИХ ПОЛУЧЕНИЕ И ИХ ПРИМЕНЕНИЕ ДЛЯ БОРЬБЫ С БАКТЕРИЯМИ p.HELICOBACTER
KR910000141A (ko) 이소옥사졸린-3-온 유도체의 항울제로서의 용도
AR018985A1 (es) Uso de una composicion farmaceutica para prevenir infecciones por vih y otras infecciones retrovirales
KR920701210A (ko) 제초성 옥사비사이클로노난 에테르

Legal Events

Date Code Title Description
FG Grant, registration